E1301
|
ECOG
|
A Phase III Randomized Study of Adjuvant Biologic Therapy in Patients With States III/IV Head and Neck Squamous Cell Carcinoma
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
E1302
|
ECOG
|
Phase III Randomized; Placebo-Controlled Trial of Docetaxel Versus Docetaxel Plus ZD1839 (Iressa; Gefitinib) in Performance Status 2 or Previously Treated Patients with Recurrent or Metastatic Head and Neck Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
E1305
|
ECOG
|
A Phase III Randomized Trial of Chemotherapy with or without Bevacizumab in Patients with Recurrent or Metastatic Head and Neck Cancer
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E1505
|
ECOG
|
A Phase III Randomized Trial of Adjuvant Chemotherapy with or without Bevacizumab for Patients with Completely Resected Stage IB (>= 4 cm) -IIIA Non-Small Cell Lung Cancer (NSCLC)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E1609
|
ECOG
|
A Phase III Randomized Study of Adjuvant Ipilimumab Anti-CTLA4 Therapy Versus High-Dose Interferon a-2b for Resected High-Risk Melanoma<br>
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E1899
|
ECOG
|
Phase III Randomized Trial for Evaluating Second Line Hormonal Therapy (Ketoconazole/Hydrocortisone) versus Docetaxel/Estramustine Combination Chemotherapy on Progression Free Survival in Asymptomatic Patients with a Rising PSA after Hormonal Therapy for Prostate Cancer
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|
E1900
|
ECOG
|
A Phase III Trial in Adult Acute Myeloid Leukemia: Daunorubicin Dose-<br>Intensification Prior to Risk-Allocated Autologous Stem Cell Transplantation
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E1910
|
ECOG
|
A Phase III Randomized Trial of Blinatumomab for Newly Diagnosed BCR-ABL-negative B lineage Acute Lymphoblastic Leukemia in Adults
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E1912
|
ECOG
|
A Randomized Phase III Study of Ibrutinib (PCI- 32765)-based Therapy vs Standard Fludarabine; Cyclophosphamide; and Rituximab (FCR) Chemoimmunotherapy in Untreated Younger Patients with Chronic Lymphocytic Leukemia (CLL)
|
Adult CIRB - Late Phase Emphasis
|
Available to Open
|
|
E1A00
|
ECOG
|
A Randomized Phase III Trial of Thalidomide (NSC #66847) Plus Dexamethasone Versus Dexamethasone in Newly Diagnosed Multiple Myeloma
|
Adult CIRB - Late Phase Emphasis
|
Completed
|
|